GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE INDIGESTION. Version 5 December 2017
|
|
- Sara Harmon
- 5 years ago
- Views:
Transcription
1 GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE INDIGESTION Version 5 December 2017 RATIFYING COMMITTEE Drugs and Therapeutics Group DATE RATIFIED MAUP EXPIRES December 2020 EXECUTIVE SPONSOR Chief Nurse MAUP ORIGINAL AUTHOR Louise Noble - Pharmacist REVIEWED BY Tracey Tugwell Pharmacy Technician KEY POLICY ISSUES: Key indication for the use of Magnesium Trisilicate Mixture Staff eligible to work under the protocol If you require this document in an alternative format, ie easy read, large text, audio, Braille or a community language please contact the Pharmacy Team on
2 GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE INDIGESTION (Magnesium Trisilicate Mixture) Version: 5 December 2017 Group Protocol drawn up by: Name Louise Noble Title Pharmacist Group Protocol authorised by: (on behalf of the Trust). Chief Medical Officer Chief Nurse Chief Pharmacist Rick Fraser Diane Hull Ray Lyon Appointed Practitioner in Charge (on behalf of the ward) Date Protocol agreed December 2017 Proposed review date December 2020 Date Protocol expires December 2020 Ward Protocol relates to
3 GROUP PROTOCOL FOR THE MANAGEMENT OF INDIGESTION 1. CLINICAL CONDITION 1.1 Clinical condition Symptoms of SIMPLE INDIGESTION (i.e. discomfort or pain in stomach and/or upper abdomen). 1.2 Inclusion Criteria Patients with the above symptoms who are otherwise well. Patients who usually self-administer at home for prophylactic symptomatic treatment of above symptoms. 1.3 Exclusion Criteria Patients under 18 years of age. Known sensitivity to magnesium trisilicate mixture. Patients with abnormally alkaline blood. Patients with low blood phosphate or calcium levels. Patients with insufficient stomach acid. Patients with severe renal failure. Patients on a low sodium diet. Patients with cirrhosis of the liver. 1.4 Action to be taken if patient is excluded from treatment under protocol Consult with ward Medical Officer 9.00 am 5.00 pm Monday to Friday. Contact duty Medical Officer out of hours if persistent or acute discomfort warrants. 1.5 Action to be taken if patient refuses treatment under protocol Discuss with ward Medical Officer if problem continues and nursing staff have significant concerns. 2. STAFF AND LOCATION 2.1 Location Inpatient units Trustwide.
4 2.2 Staff Qualified nursing staff that have been signed off as competent by the Appointed Practitioner in Charge of the ward following training and successful completion of the 'Key Aspects of Pharmacy' questionnaire for magnesium trisilicate mixture. 2.3 Continued Training Requirements. Not required unless changes to protocol 3 TREATMENT 3.1 Name of medicine Magnesium Trisilicate Mixture. 3.2 Legal status (POM, P or GSL) GSL (General sales list) 3.3 Dose or dose range and criteria for determining dose 10-20ml in a little water. 3.4 Method of route of administration Oral. 3.5 Frequency of administration Up to three times a day. Maximum period of continuous treatment must not exceed 48 hours without a medical review of the underlying symptoms. Caution If the client gets no symptomatic relief or an increase in severity, particularly if the client has a history of an MI or angina, then refer to the Medical Officer. 3.6 Follow up treatment Documented review by ward Medical Officer if needed. 3.7 Side effects and possible drug interactions Diarrhoea and burping due to release of carbon dioxide. Avoid administering at the same time as other drugs as may impair the absorption of some drugs.
5 3.8 Instruction on identifying and managing possible adverse outcomes Normal ward observations. If there is a decline in the patient s physical condition or the nurse suspects an adverse reaction, contact the ward Medical Officer or duty Medical Officer. Document concerns in patient s notes. 3.9 Arrangement for referral to medical advice Contact ward Medical Officer in normal working hours. Contact duty Medical Officer outside working hours. 4. INFORMATION AND DOCUMENTATION 4.1 Advice (including written advice) to be given to patient or carer before or after treatment. Verbal instruction on drug being administered. Provide advice to patient on a more appropriate diet. Consider raising the bed. Advise the patient or carer to inform nursing staff if symptoms persist. Offer leaflet indigestion, if appropriate. See appendix. 4.2 Details of treatment records required Completion of MAUP section of patient s drug chart. Record entry in Carenotes. This should record the presence of indigestion, and that administration of magnesium trisilicate mixture occurred in line with MAUP (or equivalent statement). 5. MANAGEMENT AND MONITORING 5.1 Advisory group approving the protocol Drugs and Therapeutics Group. 5.2 Lines of accountability Clinical Service Managers Appointed practitioner in charge
6 5.3 Method to report any adverse drug reactions to the doctor Normal ward policy for communicating with the Medical Officer. 5.4 Audit Arrangements Pharmacy supervision. Clinical audit. 5.5 Review Date and by Whom Every three years by the Drugs and Therapeutics Group or earlier if significant new evidence or manufacturers advice on Magnesium Trisilicate Mixture use is made available.
7 6. Staff authorized to work under the Group Protocol I have read the group protocol and agree to use it: - Nurses agreeing to and authorized to work under the protocol Appointed Practitioner in Charge assessing competence Name Signature Name Signature Date
8 KEY ASPECTS OF PHARMACY QUESTIONNAIRE (To be completed without access to the Protocol or drug text books, e.g. BNF.) Key aspects of pharmacy for Magnesium Trisilicate Mixture Professional's name: Grade: 1. Symptoms/criteria under which the patient will be eligible for treatment under the Protocol 2. Forms and strengths available 3. Mode of action 4. Exclusion criteria 5. Dose 6. Route of administration 7. What potentially significant side effects and drug interactions are there? 8. What written/verbal advice must be given to the patient/carer on the identification and management of significant potential side effects? I confirm that at the time of completion the answers provided showed an acceptable level knowledge. Name: Designation: Signature: Date:
9 Patient Information on Indigestion Indigestion (or dyspepsia) is discomfort or pain caused by excess stomach acid. Symptoms The discomfort or pain from indigestion is usually felt in the upper stomach or chest. Heartburn is a specific symptom of indigestion and is a burning pain caused by stomach acid flowing back into the gullet (oeophagus). Causes Your stomach produces acid that helps digest food. A layer of mucus lines the stomach, oesophagus and intestines to act as a barrier against this acid. If the mucus layer is damaged, the acid can irritate the tissues underneath. This then causes the discomfort or pain. Some of the following things can make the symptoms worse: Eating a heavy meal. Drinking excess alcohol. Pregnancy. Smoking. Drugs such as aspirin and ibuprofen. Stress and anxiety. Treatment and prevention If you smoke, try to stop. If you are over weight, try to lose weight. Avoid eating just before bed and if taking any tablets wash them down with a glass of water to avoid them sticking in your oesophagus and slowly dissolving there. Consider raising the head of your bed (one tends to slip down off extra pillows and so blocks or bricks under the head end of the bed may be better). Small meals regularly are better than large meals infrequently. Avoid tight clothing around the waist. Avoid aspirin and other anti-inflammatory medications (NSAIDs) eg ibuprofen, except after consultation with your doctor. Antacids such as Magnesium Trisilicate Mixture neutralise the acid in the stomach. Some antacids such as Gaviscon Advance Liquid contain an ingredient called an alginate which forms a barrier on the top of the stomach contents to prevent the stomach acid flowing back into the oesophagus. Various medications cause reduced acid secretion. Some of these are available over the counter and others only on prescription. If you require this document in an alternative format, ie easy read, large text, audio, Braille or a community language please contact the Pharmacy Team on Reviewed unchanged 2017
GROUP PROTOCOL FOR THE MANAGEMENT of HEARTBURN and ACID REFLUX. Version 4 January 2014
GROUP PROTOCOL FOR THE MANAGEMENT of HEARTBURN and ACID REFLUX Version 4 January 2014 RATIFYING COMMITTEE Drugs and Therapeutics Group DATE RATIFIED MAUP EXPIRES January 2017 EXECUTIVE SPONSOR Executive
More informationGROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS. Version 4 December 2017
GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS Version 4 December 2017 RATIFYING COMMITTEE Drugs and Therapeutics Group DATE RATIFIED MAUP EXPIRES December 2020 EXECUTIVE SPONSOR Chief Nurse
More informationPROTOCOL FOR THE ADMINISTRATION OF SENNA. Formulary and Prescribing Guidelines
PROTOCOL FOR THE ADMINISTRATION OF SENNA Formulary and Prescribing Guidelines Introduction This protocol allows for the administration of Senna by a registered nurse without a prescription from a doctor
More informationPROCEDURE FOR THE ADMINISTRATION OF HOMELY REMEDIES IN COMMUNITY HOSPITALS
PROCEDURE FOR THE ADMINISTRATION OF HOMELY REMEDIES IN COMMUNITY HOSPITALS Document Details Title Procedure for the administration of Homely Remedies in Community Hospitals Trust Ref No 1896-36344 Local
More informationJob Title Name Signature Date
Supply of Fluconazole 150mg capsule by Community Pharmacists working in Forth Valley Pharmacies under NHS Minor Ailment Service. Protocol Number 125 Version 5 Date protocol prepared: November 2014 Date
More informationThe use of Homely Remedies in Care Homes
Good Practice Guidance: The use of Homely Remedies in Care Homes The aim of this guidance is to: Support and advise care homes in the development of a homely remedy policy that adheres to the NICE good
More informationIBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationPATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG CAPSULES / TABLETS FOR THE FIRST- LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION
This Patient Group Direction () must only be used by registered pharmacists who have been named and authorised by their organisation to practice under it. The most recent and in date final signed version
More informationBest Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers
Medicines Management in Care Homes Best Practice Guidance for GP Practices, Community Pharmacists and Care Home Providers 1. Communication The care home manager, community pharmacist and GP surgery should
More informationName Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019
PGD4017 PATIENT GROUP DIRECTION FOR THE SUPPLY OF ACICLOVIR TABLETS FOR THE TREATMENT OF GENITAL HERPES SIMPLEX INFECTIONS by registered nurses and midwives in Integrated Sexual Health services employed
More informationNHS Lothian Patient Group Direction Version: 001
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% TO TREAT MINOR STAPHYLOCOCCAL SKIN INFECTIONS (IMPETIGO) IN PATIENTS AGED OVER 2 YEARS BY PHARMACISTS WORKING WITHIN NHS LOTHIAN COMMUNITY
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for
More informationNational Emergency Medicine Programme. Protocol for the administration of Paracetamol (Acetaminophen) at Triage in the Emergency Department
National Emergency Medicine Programme Protocol for the administration of Paracetamol (Acetaminophen) at Triage in the Emergency Date: November 2016 Table of Contents 1.0 Critical Elements... 3 2.0 Clinical
More informationPatient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019
THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Patients who require an antihistamine
More informationPlease call the Pharmacy Medicines Unit on or for a copy.
Title: PATIENT GROUP DIRECTION FOR THE SUPPLY OF FLUCONAZOLE 150MG UNDER THE MINOR AILMENT SERVICE Identifier: Across NHS Boards Organisation Wide Directorate Clinical Service Sub Department Area This
More informationSymptomatic Relief Policy Compiled by: Drug Adminstration Steering Group Date: July 2004 Review Date: July 2006
Symptomatic Relief Policy Compiled by: Drug Adminstration Steering Group Date: July 2004 Review Date: July 2006 Drug Administration Steering Group 1 Index Page Introduction 3 Clinical Conditions to which
More informationAbbvie 3D for the treatment of Hepatitis C Genotype 1
Abbvie 3D for the treatment of Hepatitis C Genotype 1 Department of Hepatology Digestive Diseases Centre Patient Information This leaflet is designed to give you important information about your new medicine.
More informationHarvoni for the treatment of Hepatitis C
Harvoni for the treatment of Hepatitis C Department of Hepatology Digestive Diseases Centre Patient Information This leaflet is designed to give you important information about your new medicine. It is
More informationPatient Group Direction For the supply of Fusidic Acid 2% Cream
Patient Group Direction For the supply of Fusidic Acid 2% Cream This Patient Group Direction (PGD) is a specific written instruction for the supply of Fusidic Acid 2% Cream to groups of patients who may
More informationNHS Fife. Patient Group Direction for Named Community Pharmacists to Supply
Patient Group Direction for Named Community Pharmacists to Supply Senna tablets 7.5mg or Senna syrup 7.5mg/5ml (Total sennosides calculated as sennoside B) For patients aged 16 years and older prescribed
More informationGastroscopy - Inpatients
PATIENT INFORMATION Gastroscopy - Inpatients Welcome to the Endoscopy Unit You have been referred by your doctor to have a Gastroscopy. This booklet has been written to explain the procedure. This will
More informationGuidance on the prescribing of medication initiated or recommended either after a private episode of care or a referral to a tertiary NHS centre
Guidance on the prescribing of medication initiated or recommended either after a private episode of care or a referral to a tertiary NHS centre GUIDELINE VERSION 2 RATIFYING COMMITTEE Drugs and Therapeutics
More informationPatient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.
Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. This document authorises the supply of Fusidic Acid Cream 2% by registered
More informationPARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationTHE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS
PGD3717 PATIENT GROUP DIRECTION FOR THESUPPLY OF METRONIDAZOLE 400mg TABLETSFOR THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS (TV) by registered nurses and midwives in Integrated Sexual
More informationOxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients
Oxfordshire Anticoagulation Service Important information about anticoagulation with vitamin K antagonists Information for patients Page 2 Your information Name:... Address:......... or patient stickie
More informationHaving a gastroscopy
Other formats Having a gastroscopy Gemini Endoscopy Suite Tel: 01271 349180 Patients name:.. Hospital No: Your appointment is at. on If you need this information in another format such as audio tape or
More informationHomely Remedies Policy
Homely Remedies Policy Endorsed by GPs in WSCCG for use in care homes in West Suffolk For adult service users in care homes with or without nursing Name of care home Signature of care home manager Definition
More informationYour primary healthcare team. Helping you and your family to receive the right healthcare at the right time
Your primary healthcare team Helping you and your family to receive the right healthcare at the right time 1 Welcome to your primary healthcare team Registering with a GP practice means you are allocated
More informationUpper GI Endoscopy a guide for patients and carers
Upper GI Endoscopy a guide for patients and carers Welcome to the Endoscopy Unit. This information leaflet is intended to provide you with information about an upper endoscopy. It is not expected to cover
More informationSupply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 1
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 Date protocol prepared: December 2015 Date protocol due for review: December 2017 This patient group direction
More informationSupply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over.
Supply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over. November 2017 Review Nov 2019 Signatures of those developing the Patient Group
More informationSupply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2 Date protocol prepared: October 2017 Date protocol due for review: October 2019 Expiry date: October
More informationName Job Title Signed Date
PGD3517 PATIENT GROUP DIRECTION FOR THE SUPPLY OF AZITHROMYCIN TABS/CAPS 250mg or TABS 500mg OR SUSPENSION 600mg/15mL FOR UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS, UNCOMPLICATED NEISSERIA GONORRHOEA
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationMeet the Pharmacy Team Experts in Medicine. Pharmacy Department
Meet the Pharmacy Team Experts in Medicine Pharmacy Department 01625 661266 Leaflet Ref: 15033 Published: 03/16 Review: 03/19 Page 1 Our role on the ward Your ward based pharmacy team consists of a pharmacist
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain
More informationPATIENT GROUP DIRECTION
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% FOR THE TREATMENT OF IMPETIGO BY COMMUNITY PHARMACISTS UNDER THE PHARMACY FIRST SERVICE IN NHS HIGHLAND THE COMMUNITY PHARMACIST SEEKING
More informationProcedure to Allow Nursing Staff to Dispense Leave and Discharge Medication
Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication Version 2 minor update June 2013 Procedure Number Replaces Policy No. Ratifying Committee N/a PPPF Date Ratified April 2009 Minor
More informationPATIENT GROUP DIRECTION. Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix )
PATIENT GROUP DIRECTION Administration of: By: Practice Nurses Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix ) In: General Practice It is the responsibility of the professional working
More informationCLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical
More informationReduce general practice consultations and prescriptions for minor conditions suitable for self-care
Reduce general practice consultations and prescriptions for minor conditions suitable for self-care To be read in conjunction with the following CCG policies: Joint Formulary C03 Low Priority Procedures
More informationDiagnostic Upper Gastrointestinal Endoscopy
Diagnostic Upper Gastrointestinal Endoscopy Endoscopy Department Patient information leaflet This leaflet explains more about having a gastroscopy, including the benefits, risks and any alternatives and
More informationPROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS
STANDARD OPERATING PROCEDURE PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS Issue History Issue Version one Purpose of Issue/Description of Change To facilitate patients
More informationPatient Group Direction (PGD) template
Patient Group Direction (PGD) template Initial supply of doxycycline 100mg capsules to adults and children aged eight (8) years and over exposed to a suspected biological agent Version no: 2014/2 Valid
More informationGG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria:
More informationNorthumbria Healthcare NHS Foundation Trust. Your guide to having a combined Gastroscopy and Colonoscopy. Issued by the Endoscopy Team
Northumbria Healthcare NHS Foundation Trust Your guide to having a combined Gastroscopy and Colonoscopy Issued by the Endoscopy Team You have been referred for a combined gastroscopy and colonoscopy. This
More informationPatient Information Leaflet. Gastroscopy. Prepared by Endoscopy Department
Patient Information Leaflet Gastroscopy Prepared by Endoscopy Department February 2013 Review due February 2016 1 If you require this leaflet in another language, large print or another format, please
More informationBEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING
BEST PRACTICE GUIDANCE-SUPPLEMENTARY PRESCRIBING NON MEDICAL PRESCRIBING ADVISOR IMPLEMENTATION DATE: MAY 2009 REVIEW DATE: MAY 2010 Supplementary Prescribing The working definition of supplementary prescribing
More informationNasogastric tube feeding
What is nasogastric tube feeding? Nasogastric (NG) feeding is where a narrow feeding tube is placed through your nose down into your stomach. The tube can be used to give you fluids, medications and liquid
More informationTemplate (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment
Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment The PRN Purpose & Outcome Protocol (PRN POP) Background The term PRN (from
More informationStandard Operating Procedure for When required (PRN) medicines in care homes
Standard Operating Procedure for When required (PRN) medicines in care homes Introduction All health and social care organisations are responsible for ensuring the safe management of all medicines. This
More informationHaving a Gastroscopy. A guide to the test. Information for patients
Having a Gastroscopy A guide to the test Information for patients Your doctor has recommended that you have a gastrointestinal endoscopy, this is sometimes called a Gastroscopy or Endoscopy. This leaflet
More informationGastroscopy. Please bring this booklet with you to your appointment. Oesophago-gastro duodenoscopy (OGD)
Gastroscopy Oesophago-gastro duodenoscopy (OGD) Your appointment details, information about the examination, and consent form Please bring this booklet with you to your appointment 1 2 Your appointment
More informationWhipple Procedure (Pancreaticoduodenectomy)
Enhanced Recovery After Whipple Procedure (Pancreaticoduodenectomy) Your Path to Healing Your Pancreatic Surgical Oncology Team This expert team is an important part of the Pancreatic Surgery Program at
More informationMEDICINES RECONCILIATION GUIDELINE Document Reference
MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012
More informationPATIENT GROUP DIRECTION (PGD) FOR Metronidazole 400mg Tablets
Antibiotic Oral (tablet/capsule/suspension) PATIENT GROUP DIRECTION (PGD) FOR YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Caution: This
More informationIf you have any questions about the risks of this procedure please ask the endoscopist doing the test or the person who has referred you.
What is a gastroscopy? A gastroscopy is an examination of the lining of the gullet (oesophagus), stomach, and first part of the small bowel (duodenum). It involves an endoscope (a thin, flexible tube with
More informationConsultation Group: See relevant page in the PGD. Review Date: October 2015
Patient Group Direction For The Supply Of Trimethoprim For The Treatment Of Women With Uncomplicated Urinary Tract Infections By Nurses And Pharmacists Working Within NHS Grampian Community Pharmacies
More informationFlexible Sigmoidoscopy Inpatients
PATIENT INFORMATION Flexible Sigmoidoscopy Inpatients Your doctor has requested this procedure to help investigate your medical condition to aid your diagnosis and management. This booklet has been written
More informationLaparoscopic Nissen Fundoplication
Information for patients This leaflet can be made available in other formats including large print, CD and Braille and in languages other than English, upon request. This leaflet tells you about Laparoscopic
More informationManaging medicines in care homes
Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience
More informationxrfslt \j,3 0+ {6^1 Otc(L!?i:lr+ NHS FIFE PRIMARY CARE THIS PATIENT GROUP DIRECTION HAS BEEN APPROVED BY:
NHS FIFE PRIMARY CARE Patient Group Direction for Named Nurses in Contraception and Sexual Health Clinics to Supply Clotrim azole lo/o cream TO WOMEN CLIENTS for use in the treatment of vaginal candidiasis
More informationEndoscopy Department Patient Information Gastroscopy with Oesophageal Dilation
Endoscopy Department Patient Information Gastroscopy with Oesophageal Dilation This leaflet provides information about the Endoscopy and Dilation procedure. It aims to answer any questions you may have
More informationEndoscopy Unit Having an Oesophageal Stent insertion
Endoscopy Unit Having an Oesophageal Stent insertion Information for patients Your doctor has recommended that you have an Oesophageal Stent Insertion. This leaflet will explain the procedure and what
More informationSocial care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationInformation for patients receiving long term hormone treatment and radiotherapy for prostate cancer
Information for patients receiving long term hormone treatment and radiotherapy for prostate cancer Northern Centre for Cancer Care (NCCC) Freeman Hospital Introduction This leaflet has been written to
More informationLaparoscopic cholecystectomy
Laparoscopic cholecystectomy Information for day surgery patients at King s College Hospital only This leaflet answers some of the questions you may have about having a laparoscopic cholecystectomy. It
More informationPage 17. Medication Management Policy and Practice Guidelines
Page 17 APPENDIX A Medication Management Policy and Practice Guidelines Index Scope Definition of medication Principles underpinning safe use of medications Procedure Guidelines Scope 1. Medication packaging
More informationCoordinating Access to Obtain ZOLINZA
ACT Now: 1-866-363-6379 Coordinating Access to Obtain ZOLINZA Reimbursement Support Services Patient Assistance BEFORE YOU LEAVE, please have your physician s office fax your prescription for ZOLINZA and
More informationAppendix 3 Cardiac Catheter Lab at Musgrove Park Hospital PATIENT GROUP DIRECTION (PGD)
Appendix 3 Cardiac Catheter Lab at Musgrove Park Hospital PATIENT GROUP DIRECTION (PGD) PGD for the supply/administration of: Lidocaine 1% and Adrenaline 1:200,000 Master document reference number: This
More informationPATIENT GROUP DIRECTION (PGD) FOR
Antibiotic Oral (tablet/capsule/suspension) PATIENT GROUP DIRECTION (PGD) FOR YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Caution: This
More information2. Short term prescription medication and drugs (administered for less than two weeks):
Medication Administration Procedure This is a companion document with Policy # 516 Student Medication To access the policy: click on Policies (under the District Information heading) The Licensed School
More informationModule 7. Tips for Family and Friends
Module 7 Tips for Family and Friends The Heart Failure Society of America (HFSA) is a non-profit organization of health care professionals and researchers who are dedicated to enhancing quality and duration
More informationOesophago-Gastro Duodenoscopy (OGD) with Haemostasis
South Tyneside NHS Foundation Trust Oesophago-Gastro Duodenoscopy (OGD) with Haemostasis Patient information booklet Endoscopy Unit Providing a range of NHS services in Gateshead, South Tyneside and Sunderland.
More informationTransnasal Endoscopy (TNE)
Transnasal Endoscopy (TNE) Information for you Follow us on Twitter @NHSaaa Find us on Facebook at www.facebook.com/nhsaaa Visit our website: www.nhsaaa.net All our publications are available in other
More informationHaving a staging laparoscopy
Information for patients Having a staging laparoscopy Turnberg Building Upper GI General Surgery 0161 206 5062 Page 1 of 5 This booklet has four aims: l To help you and your family become better informed
More informationPROCEDURE FOR ADMINISTRATION OF ORAL MEDICINES FOR CHILDREN IN THE COMMUNITY
PROCEDURE FOR ADMINISTRATION OF ORAL MEDICINES FOR CHILDREN IN THE COMMUNITY This has been adopted in full by The Solent Academies Trust Purpose of Agreement This document states the procedure for giving
More informationPATIENT GROUP DIRECTION (PGD) FOR Amoxicillin 250mg/5ml Suspension
Antibiotic Oral (tablet/capsule/suspension) PATIENT GROUP DIRECTION (PGD) FOR YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Caution: This
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients
The Newcastle upon Tyne Hospitals NHS Foundation Trust Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients Version.: 2.0 Effective From: 15 March 2018 Expiry Date: 15 March
More informationDIVISION OF HEALTHCARE FINANCING. Many health problems begin before your children look or feel sick
VOLUME 10, ISSUE 1 MARCH 2013 HEALTH CHECK DIVISION OF HEALTHCARE FINANCING ` WHO NEEDS A WELL CHILD CHECK-UP? Inside this issue: Over-The-Counter Pain Relievers Over-The-Counter Pain Relievers Cont. 2
More informationThoracic surgery medicines
Addressograph Name: Date of birth: Hosp No: NHS No: Thoracic surgery medicines A patient s guide Medicine name Date last dose to be taken 1 Introduction This booklet is for patients waiting to have thoracic
More informationYou and your gastrostomy feeding tube
The Clatterbridge Cancer Centre NHS Foundation Trust You and your gastrostomy feeding tube Rehabilitation and Support A guide for patients and carers Contents Skin care...1 Daily tube care...2 Feeding
More informationWelcome to OPEN DOORS
Welcome to OPEN DOORS A support program for IPF patients taking OFEV (nintedanib) capsules For more information, call OPEN DOORS at 1-866-OPENDOOR (1-866-673-6366), or visit www.ofev.com IPF=idiopathic
More informationToolbox Talks. Access
Access The detail of what the Healthcare Charter says in relation to what service users can expect and what they can do to help in relation to this theme is outlined overleaf. 1. How do you ensure that
More informationCLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)
CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) DEFINITION A Patient Group Direction (PGD) is a specific written instruction for the supply and administration
More informationPOLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case
POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case DOCUMENT NO: DN116 Lead author/initiator(s): Sarah Woodley Community Health Services Pharmacist sarah.woodley@ccs.nhs.uk
More informationInformation for Patients
Having a Radiologically Inserted Gastrostomy (RIG) Information for Patients In this leaflet: Introduction.. 2 What is a RIG feeding tube?. 2 Why do I need a RIG?. 2 Are there any risks?.2 Are there any
More informationEnhanced recovery after bowel surgery
Patient information - Bowel Pre-operative Surgery Enhanced Assessment Recovery - WLE Enhanced recovery after bowel surgery Introduction This leaflet will explain what will happen when you come to the hospital
More informationPalliative Care Anticipatory Prescribing
Palliative Care Anticipatory Prescribing Guidelines Gippsland Region Palliative Care Consortium Clinical Practice Group Policy No. Title Keywords Ratified GRPCC-CPG008 Anticipatory Prescribing Guidelines
More informationEl Paso Integrated Physicians Group. Overview
El Paso Integrated Physicians Group Protocol Name Protocol Number Infusion Services 01 Effective Date 6/1/2015 Supersedes Protocol Dated N/A Overview This clinical protocol defines requirements and activities
More informationFlexible sigmoidoscopy and rectal bleeding clinic
Flexible sigmoidoscopy and rectal bleeding clinic This leaflet will explain what will happen when you come to attend the One-stop Rectal Bleed Clinic. If you have any questions or concerns, please speak
More informationHaving a Gastroscopy Information for Patients
Endoscopy Team Information for Patients Having a Gastroscopy Information for Patients What is a Gastroscopy? You have been advised to have a gastroscopy to help find the cause of your symptoms. A gastroscopy
More informationOPAT CELLULITIS PATHWAY
OPAT CELLULITIS PATHWAY ANY exclusion criteria for OPAT Sepsis syndrome Active drug/alcohol abuse Active underlying orthopaedic condition Craniofacial cellulitis Failure to improve with > 48hrs IV Rx YES
More informationNew v1.0 Date: Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee
Clinical Pharmacy Services: SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key Words:
More informationPurpose: This document states the procedure for giving medicines via nasogastric tube, gastrostomy and jejunostomy to children in the community
The Redway School Procedure for Administration of Medicines via External Feeding Tubes Purpose: This document states the procedure for giving medicines via nasogastric tube, gastrostomy and jejunostomy
More informationDr Vincent Kirchner, MEDICAL DIRECTOR. Date Version Summary of amendments Oct New Procedure
OLANZAPINE DEPOT PROCEDURE OCTOBER 2017 Policy title Policy reference Policy category Relevant to Date published Implementatio n date Date last reviewed Next review date Policy lead Contact details Accountable
More informationCarePartners Nursing Care Plan Anticoagulant Therapy
CarePartners Nursing Care Plan Anticoagulant Therapy ** If a CarePartners wound pathway, palliative care plan or oncology care plan is being used to guide the patient s care, this Nursing Care Plan may
More informationSection 6: Referral record headings
Section 6: Referral record headings Referral record standards: the referral headings are primarily intended for recording the clinical information in referral communication between general practitioners
More information